In what U.S. FDA commissioner Stephen Hahn billed as “a major milestone” in testing for the COVID-19 pandemic, the FDA has granted an emergency use authorization (EUA) to Ellume Ltd., of East Brisbane ...

CAMBRIDGE & WETHERBY, England--(BUSINESS WIRE)--Avacta Group plc (AIM: AVCT), a clinical stage biopharmaceutical company developing innovative cancer therapies and powerful diagnostics based on its ...

Scientists and public health experts built the COVID-19 pandemic response on years of experience navigating infectious disease outbreaks. Although lateral flow immunoassays have been central to ...

CAMBRIDGE, England & WETHERBY, England--(BUSINESS WIRE)--Avacta Group plc (AIM: AVCT), the developer of innovative cancer therapies and diagnostics based on its proprietary Affimer ® and pre|CISION ™ ...

A Covid-19 lateral flow test showing a negative result. Routine testing to identify those infected followed by efficient contact tracing, and supported isolation is still the most effective public ...

In a recent review published in Nature Reviews Bioengineering, researchers assessed the changing landscape of lateral flow tests (LFTs), and the development of next-generation LFTs based on lessons ...

A study led by Queen Mary University of London and University of Oxford has found that lateral flow tests detect Covid-19 with similar accuracy to laboratory-based PCR tests, providing they are used ...

The performance of lateral flow (antigen) tests commonly used to detect COVID-19 infection in children falls short of the minimum criteria set by the World Health Organization (WHO) and US and UK ...

Avacta to replace antibodies in AffiDX test Finds test is less sensitive to Omicron at lower viral loads No timeline for sales resumption, shares plunge 26.5% Jan 10 (Reuters) - Britain's Avacta Group ...

An artificial intelligence app to read COVID-19 lateral flow tests helped to reduce false results in a recent trial. An artificial intelligence app to read COVID-19 lateral flow tests helped to reduce ...

Add Yahoo as a preferred source to see more of our stories on Google. FILE PHOTO: Testing of a lateral flow antigen test facility in St Andrews LONDON (Reuters) - Scientists and advisers are resisting ...